STAT

Opinion: Cardiovascular disease: the next great challenge for HIV care

As people infected with HIV live longer, cardiovascular disease has begun to emerge as a particularly troubling health problem for them.

On the first World AIDS Day in 1988, the outlook was bleak for people living with this strange, new, and deadly disease. Few could imagine the amazing progress to come in HIV treatment that has allowed millions of people around the world to live longer and healthier lives. The remarkable successes in treating HIV have led to a new challenge: Age-related chronic conditions have become a growing problem among people living with HIV in the United States and are poised to become a serious problem globally.

This World AIDS

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related